{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:29:26Z","timestamp":1792427366736,"version":"4.5.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.pt.2016.03.002","type":"journal-article","created":{"date-parts":[[2016,4,3]],"date-time":"2016-04-03T11:33:29Z","timestamp":1459683209000},"page":"458-469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":295,"title":["Current Threat of Triclabendazole Resistance in Fasciola hepatica"],"prefix":"10.1016","volume":"32","author":[{"given":"Jane M.","family":"Kelley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Beddoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Skuce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry W.","family":"Spithill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2016.03.002_bib0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0020-7519(87)90121-4","article-title":"The impact on production and mechanisms of pathogenesis of trematode infections in cattle and sheep","volume":"17","author":"Dargie","year":"1987","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0010","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1017\/S0031182013001662","article-title":"Recent advances in the diagnosis, impact on production and prediction of Fasciola hepatica in cattle","volume":"141","author":"Charlier","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2016.03.002_bib0015","series-title":"Fasciolosis","first-page":"465","article-title":"Fasciola gigantica: epidemiology, control, immunology and molecular biology","author":"Spithill","year":"1999"},{"key":"10.1016\/j.pt.2016.03.002_bib0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/tvjl.1999.0377","article-title":"Fasciolicides: efficacy, actions, resistance and its management","volume":"158","author":"Fairweather","year":"1999","journal-title":"Vet. J."},{"key":"10.1016\/j.pt.2016.03.002_bib0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/vr.113.14.315","article-title":"Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole","volume":"113","author":"Boray","year":"1983","journal-title":"Vet. Rec."},{"key":"10.1016\/j.pt.2016.03.002_bib0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1079\/JOH2005298","article-title":"Triclabendazole: new skills to unravel an old(ish) enigma","volume":"79","author":"Fairweather","year":"2005","journal-title":"J. Helminthol."},{"key":"10.1016\/j.pt.2016.03.002_bib0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.yexmp.2007.01.009","article-title":"Understanding triclabendazole resistance","volume":"82","author":"Brennan","year":"2007","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.pt.2016.03.002_bib0040","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1017\/S0031182013000528","article-title":"Identification of putative markers of triclabendazole resistance by a genome-wide analysis of genetically recombinant Fasciola hepatica","volume":"140","author":"Hodgkinson","year":"2013","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2016.03.002_bib0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S0022149X09321173","article-title":"Triclabendazole progress report 2005-2009: an advancement of learning?","volume":"83","author":"Fairweather","year":"2009","journal-title":"Helminthology"},{"key":"10.1016\/j.pt.2016.03.002_bib0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vetpar.2011.05.034","article-title":"Reducing the future threat from (liver) fluke: realistic prospect or quixotic fantasy?","volume":"180","author":"Fairweather","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2010.12.011","article-title":"Liver fluke isolates: a question of provenance","volume":"176","author":"Fairweather","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0060","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/vr.d2867","article-title":"Raising the bar on reporting \u2018triclabendazole resistance\u2019","volume":"168","author":"Fairweather","year":"2011","journal-title":"Vet. Rec."},{"key":"10.1016\/j.pt.2016.03.002_bib0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/vr.c5332","article-title":"Diagnosis and economic consequences of triclabendazole resistance in Fasciola hepatica in a sheep flock in south-east Scotland","volume":"168","author":"Sargison","year":"2011","journal-title":"Vet. Rec."},{"key":"10.1016\/j.pt.2016.03.002_bib0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1751-0813.1995.tb03546.x","article-title":"Resistance of Fasciola hepatica to triclabendazole","volume":"72","author":"Overend","year":"1995","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.pt.2016.03.002_bib0075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/vr.h4793","article-title":"Raising awareness of sustainable management of liver fluke in sheep","volume":"177","author":"Anon","year":"2015","journal-title":"Vet. Rec."},{"key":"10.1016\/j.pt.2016.03.002_bib0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0304-4017(00)00267-3","article-title":"Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The Netherlands","volume":"91","author":"Moll","year":"2000","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0085","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0020-7519(99)00074-0","article-title":"Selection for anthelmintic resistance by macrocyclic lactones in Haemonchus contortus","volume":"29","author":"Le Jambre","year":"1999","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0304-4017(95)00806-2","article-title":"World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition of guidelines for evaluating the efficacy of anthelmintics in ruminants (bovine, ovine, caprine)","volume":"58","author":"Wood","year":"1995","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpddr.2013.11.005","article-title":"Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle","volume":"4","author":"Brockwell","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Res."},{"key":"10.1016\/j.pt.2016.03.002_bib0100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.vetpar.2010.10.057","article-title":"Comparison of two assays, a faecal egg count reduction test (FECRT) and a coproantigen reduction test (CRT), for the diagnosis of resistance to triclabendazole in Fasciola hepatica in sheep","volume":"176","author":"Flanagan","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.vetpar.2010.10.037","article-title":"Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica","volume":"176","author":"Flanagan","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0110","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1645\/GE-192R","article-title":"An ultrasensitive capture ELISA for detection of Fasciola hepatica coproantigens in sheep and cattle using a new monoclonal antibody (MM3)","volume":"90","author":"Mezo","year":"2004","journal-title":"J. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0115","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.vetpar.2012.02.009","article-title":"On farm evaluation of the coproantigen ELISA and coproantigen reduction test in Scottish sheep naturally infected with Fasciola hepatica","volume":"187","author":"Gordon","year":"2012","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.vetpar.2008.01.035","article-title":"Qualitative and quantitative evaluation of coprological and serological techniques for the diagnosis of fasciolosis in cattle","volume":"153","author":"Charlier","year":"2008","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.vetpar.2013.04.012","article-title":"Comparative kinetics of serological and coproantigen ELISA and faecal egg count in cattle experimentally infected with Fasciola hepatica and following treatment with triclabendazole","volume":"196","author":"Brockwell","year":"2013","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0130","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.vetpar.2010.12.047","article-title":"Resistance of Fasciola hepatica against triclabendazole in cattle in Patagonia (Argentina)","volume":"178","author":"Olaechea","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0135","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.vetpar.2013.01.001","article-title":"Resistance of Fasciola hepatica against triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep","volume":"195","author":"Ortiz","year":"2013","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.vetpar.2015.02.014","article-title":"High prevalence of fasciolosis and evaluation of drug efficacy against Fasciola hepatica in dairy cattle in the Maffra and Bairnsdale districts of Gippsland, Victoria, Australia","volume":"209","author":"Elliott","year":"2015","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/vr.e5381","article-title":"Confirmation of triclabendazole resistance in liver fluke in the UK","volume":"171","author":"Gordon","year":"2012","journal-title":"Vet. Rec."},{"key":"10.1016\/j.pt.2016.03.002_bib0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/vr.100588","article-title":"Composite faecal egg count reduction test to detect resistance to triclabendazole in Fasciola hepatica","volume":"171","author":"Daniel","year":"2012","journal-title":"Vet. Rec."},{"key":"10.1016\/j.pt.2016.03.002_bib0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.vetpar.2014.11.016","article-title":"Fasciola hepatica: a comparative survey of adult fluke resistance to triclabendazole, nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting, coproantigen ELISA testing and fluke histology","volume":"207","author":"Hanna","year":"2015","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0160","unstructured":"Hassell, C. and Chapman, V. (2012) Case report: suspect lack of triclabendazole efficacy in liver fluke in sheep in the Taranaki. Proceedings of the Society of Sheep and Beef Cattle Veterinarians of the New Zealand Veterinary Association 2012, 4.14.1\u20134.14.2"},{"key":"10.1016\/j.pt.2016.03.002_bib0165","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vetpar.2009.05.017","article-title":"The comparative efficacy of four anthelmintics against a natural acquired Fasciola hepatica infection in hill sheep flock in the west of Ireland","volume":"164","author":"Mooney","year":"2009","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0170","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.vetpar.2015.11.018","article-title":"Liver fluke control on sheep farms in Northern Ireland: a survey of changing management practices in relation to disease prevalence and perceived triclabendazole resistance","volume":"216","author":"McMahon","year":"2015","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0175","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/vr.146.17.504-a","article-title":"Activity of closantel against adult triclabendazole-resistant Fasciola hepatica","volume":"146","author":"Coles","year":"2000","journal-title":"Vet. Rec."},{"key":"10.1016\/j.pt.2016.03.002_bib0180","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/vr.148.23.723","article-title":"Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole resistant Fasciola hepatica","volume":"148","author":"Coles","year":"2001","journal-title":"Vet. Rec."},{"key":"10.1016\/j.pt.2016.03.002_bib0185","doi-asserted-by":"crossref","first-page":"e16126","DOI":"10.1371\/journal.pone.0016126","article-title":"Predicting impacts of climate change on Fasciola hepatica risk","volume":"6","author":"Fox","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pt.2016.03.002_bib0190","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4081\/gh.2015.352","article-title":"Modelling recent and future climatic suitability for fasciolosis in Europe","volume":"9","author":"Caminade","year":"2015","journal-title":"Geospat. Health"},{"key":"10.1016\/j.pt.2016.03.002_bib0195","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.ijpara.2005.07.010","article-title":"Fascioliasis and other plant-borne trematode zoonoses","volume":"35","author":"Mas-Coma","year":"2005","journal-title":"Int. J Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0200","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3201\/eid1806.120302","article-title":"Apparent triclabendazole-resistant human Fasciola hepatica infection, the Netherlands","volume":"18","author":"Winkelhagen","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.pt.2016.03.002_bib0205","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.4067\/S0034-98872014001000014","article-title":"Resistant human fascioliasis: report of four patients","volume":"142","author":"Gil","year":"2014","journal-title":"Rev. Med. Chil."},{"key":"10.1016\/j.pt.2016.03.002_bib0210","first-page":"27","article-title":"Partial hepatectomy for the resistant Fasciola hepatica infection in a child","volume":"6","author":"G\u00fclhan","year":"2015","journal-title":"APSP J. Case Rep."},{"key":"10.1016\/j.pt.2016.03.002_bib0215","doi-asserted-by":"crossref","first-page":"e0004361","DOI":"10.1371\/journal.pntd.0004361","article-title":"Treatment failure after multiple courses of triclabendazole among patients with fascioliasis in Cusco, Peru: a case series","volume":"10","author":"Cabada","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2016.03.002_bib0220","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1017\/S003118200100124X","article-title":"Triclabendazole-resistant Fasciola hepatica: \u03b2-tubulin and response to in vitro treatment with triclabendazole","volume":"124","author":"Robinson","year":"2002","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2016.03.002_bib0225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1017\/S0031182006000114","article-title":"Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha","volume":"133","author":"McConville","year":"2006","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2016.03.002_bib0230","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1017\/S003118200800543X","article-title":"Molecular detection of benzimidazole resistance in Haemonchus contortus using real-time PCR and pyrosequencing","volume":"136","author":"von Samson-Himmelstjerna","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2016.03.002_bib0235","doi-asserted-by":"crossref","first-page":"e64337","DOI":"10.1371\/journal.pone.0064337","article-title":"The small molecule triclabendazole decreases the intracellular level of cyclic AMP and increases resistance to stress in Saccharomyces cerevisiae","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pt.2016.03.002_bib0240","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1126\/science.156397","article-title":"Chemotherapy of parasitic worms: new biochemical strategies","volume":"205","author":"Mansour","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.pt.2016.03.002_bib0245","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF00932235","article-title":"Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex)","volume":"79","author":"Stitt","year":"1993","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.pt.2016.03.002_bib0250","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1017\/S0031182000077428","article-title":"The effect of the sulphoxide metabolite of triclabendazole (\u2018Fasinex\u2019) on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica","volume":"108","author":"Stitt","year":"1994","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2016.03.002_bib0255","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1074\/mcp.M300139-MCP200","article-title":"Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors","volume":"3","author":"Brehmer","year":"2004","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.pt.2016.03.002_bib0260","doi-asserted-by":"crossref","first-page":"13947","DOI":"10.1021\/bi061874m","article-title":"Proteome-wide profiling of isoniazid targets in Mycobacterium tuberculosis","volume":"45","author":"Argyrou","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.pt.2016.03.002_bib0265","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.exppara.2014.03.013","article-title":"Trypanosoma cruzi chemical proteomics using immobilized benznidazole","volume":"140","author":"Trochine","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0270","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1017\/S0031182013000814","article-title":"Determination of antiprotozoal drug mechanisms by metabolomics approaches","volume":"141","author":"Creek","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2016.03.002_bib0275","doi-asserted-by":"crossref","first-page":"e2844","DOI":"10.1371\/journal.pntd.0002844","article-title":"Benznidazole biotransformation and multiple targets in Trypanosoma cruzi revealed by metabolomics","volume":"8","author":"Trochine","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2016.03.002_bib0280","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00436-011-2304-9","article-title":"Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica","volume":"109","author":"Devine","year":"2011","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.pt.2016.03.002_bib0285","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1017\/S0031182010001125","article-title":"Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica","volume":"138","author":"Devine","year":"2011","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2016.03.002_bib0290","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.vetpar.2011.08.006","article-title":"Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole","volume":"184","author":"Devine","year":"2012","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0295","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1017\/S0031182013000759","article-title":"Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil","volume":"140","author":"Meaney","year":"2013","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2016.03.002_bib0300","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.exppara.2013.09.015","article-title":"Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil","volume":"135","author":"Savage","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0305","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molbiopara.2012.08.008","article-title":"An amino acid substitution in Fasciola hepatica P-glycoprotein from triclabendazole-resistant and triclabendazole-susceptible populations","volume":"186","author":"Wilkinson","year":"2012","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0310","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molbiopara.2014.11.006","article-title":"The T687G SNP in a P-glycoprotein gene of Fasciola hepatica is not associated with resistance to triclabendazole in two resistant Australian populations","volume":"198","author":"Elliott","year":"2014","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0315","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpddr.2014.07.007","article-title":"Recent advances in candidate-gene and whole-genome approaches to the discovery of anthelmintic resistance markers and the description of drug\/receptor interactions","volume":"4","author":"Kotze","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Res."},{"key":"10.1016\/j.pt.2016.03.002_bib0320","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.exppara.2015.10.007","article-title":"A single amino acid substitution in isozyme GST mu in triclabendazole resistant Fasciola hepatica (Sligo strain) can substantially influence the manifestation of anthelmintic resistance","volume":"159","author":"Fern\u00e1ndez","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0325","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1021\/pr1000785","article-title":"Comparative proteomic analysis of triclabendazole response in the liver fluke Fasciola hepatica","volume":"9","author":"Chemale","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.pt.2016.03.002_bib0330","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jprot.2014.02.030","article-title":"A quantitative proteomic screen to identify potential drug resistance mechanism in \u03b1-difluoromethylornithine (DFMO) resistant Leishmania donovani","volume":"102","author":"Singh","year":"2014","journal-title":"J. Proteomics"},{"key":"10.1016\/j.pt.2016.03.002_bib0335","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpddr.2014.05.002","article-title":"Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum","volume":"4","author":"Brotherton","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Res."},{"key":"10.1016\/j.pt.2016.03.002_bib0340","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00436-006-0440-4","article-title":"Evidence for multiple mitochondrial lineages of Fasciola hepatica (liver fluke) within infrapopulations from cattle and sheep","volume":"101","author":"Walker","year":"2007","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.pt.2016.03.002_bib0345","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.vetpar.2013.11.019","article-title":"Evidence for high genetic diversity of NAD1 and COX1 mitochondrial haplotypes among triclabendazole resistant and susceptible populations and field isolates of Fasciola hepatica (liver fluke) in Australia","volume":"200","author":"Elliott","year":"2014","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0350","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1017\/S0031182010001149","article-title":"Population dynamics of the liver fluke, Fasciola hepatica: the effect of time and spatial separation on the genetic diversity of fluke populations in the Netherlands","volume":"138","author":"Walker","year":"2011","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2016.03.002_bib0355","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1515\/znc-2005-9-1018","article-title":"Understanding genetic diversity of the liver fluke Fasciola hepatica","volume":"60","author":"Dosay-Akbulut","year":"2005","journal-title":"Z. Naturforsch. C."},{"key":"10.1016\/j.pt.2016.03.002_bib0360","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13059-015-0632-2","article-title":"The Fasciola hepatica genome: gene duplication and polymorphism reveals adaptation to the host environment and the capacity for rapid evolution","volume":"16","author":"Cwiklinski","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.pt.2016.03.002_bib0365","doi-asserted-by":"crossref","first-page":"6","DOI":"10.12968\/live.2015.20.2.86","article-title":"Triclabendazole-resistant liver fluke: issues and strategies","volume":"20","author":"Crilly","year":"2015","journal-title":"Livestock"},{"key":"10.1016\/j.pt.2016.03.002_bib0370","first-page":"1","article-title":"Liver fluke disease in sheep and cattle. Department of Primary Industries NSW, Australia","volume":"446","author":"Boray","year":"2007","journal-title":"Primefacts"},{"key":"10.1016\/j.pt.2016.03.002_bib0375","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpddr.2015.07.003","article-title":"First report of closantel treatment failure against Fasciola hepatica in cattle","volume":"5","author":"Novobilsk\u00fd","year":"2015","journal-title":"Int. J. Parasitol. Drugs Drug Res."},{"key":"10.1016\/j.pt.2016.03.002_bib0380","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.exppara.2013.10.010","article-title":"Efficacy of an anthelmintic combination in sheep infected with Fasciola hepatica resistant to albendazole and clorsulon","volume":"136","author":"Mart\u00ednez-Valladares","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0385","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ijpara.2014.07.011","article-title":"Liver fluke vaccines in ruminants: strategies, progress and future opportunities","volume":"44","author":"Toet","year":"2014","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0390","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0007-1935(17)34136-2","article-title":"Production effects of liver fluke in cattle. The effects of infection on liveweight gain, feed intake and food conversion efficiency in beef cattle","volume":"133","author":"Hope Cawdery","year":"1977","journal-title":"Brit. Vet. J."},{"key":"10.1016\/j.pt.2016.03.002_bib0395","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-4017(01)00431-9","article-title":"Treatment vs non-treatment of helminth infections in cattle: defining the threshold","volume":"98","author":"Vercruysse","year":"2001","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0400","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijpara.2010.09.003","article-title":"Relative importance of management, meteorological and environmental factors in the spatial distribution of Fasciola hepatica in dairy cattle in a temperate climate zone","volume":"41","author":"Bennema","year":"2011","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0405","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.vetpar.2014.12.010","article-title":"The effects of farm management practices on liver fluke prevalence and the current internal parasite control measures employed on Irish dairy farms","volume":"207","author":"Selemetas","year":"2015","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0410","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/vr.e5357","article-title":"Diagnosis of triclabendazole resistance in Fasciola hepatica","volume":"171","author":"Sargison","year":"2012","journal-title":"Vet. Rec."},{"key":"10.1016\/j.pt.2016.03.002_bib0415","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1751-0813.1969.tb16088.x","article-title":"The epidemiology of fasciolosis in two representative endemic regions of Australia","volume":"45","author":"Boray","year":"1969","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.pt.2016.03.002_bib0420","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.vetpar.2009.03.027","article-title":"Sheep helminth parasitic disease in south eastern Scotland arising as a possible consequence of climate change","volume":"163","author":"Kenyon","year":"2009","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0425","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0065-308X(08)60363-2","article-title":"Relationships between the species of Fasciola and their molluscan hosts","volume":"3","author":"Kendall","year":"1965","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0430","first-page":"315","article-title":"Viability of Fasciola hepatica metacercariae in silage Vet","volume":"31","author":"Wikerhauser","year":"1961","journal-title":"Arhiv."},{"key":"10.1016\/j.pt.2016.03.002_bib0435","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0020-7519(97)00183-5","article-title":"From discovery to eradication of schistosomiasis in Japan: 1847\u20131996","volume":"27","author":"Tanaka","year":"1997","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0440","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/vr.157.19.578","article-title":"Emergence of fasciolosis in cattle in East Anglia","volume":"157","author":"Pritchard","year":"2005","journal-title":"Vet. Rec."},{"key":"10.1016\/j.pt.2016.03.002_bib0445","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.vetpar.2015.01.004","article-title":"Fasciola hepatica vaccine: we may not be there yet but we\u2019re on the right road","volume":"208","author":"Molina-Hern\u00e1ndez","year":"2015","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0450","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.vetpar.2012.11.033","article-title":"Identification of a field isolate of Fasciola hepatica resistant to albendazole and susceptible to triclabendazole","volume":"193","author":"Sanabria","year":"2013","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0455","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/vr.159.13.424","article-title":"Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain","volume":"159","author":"Alvarez-Sanchez","year":"2006","journal-title":"Vet. Rec."},{"key":"10.1016\/j.pt.2016.03.002_bib0460","first-page":"399","article-title":"Triclabendazole-resistant liver fluke in Scottish sheep","volume":"143","author":"Mitchell","year":"1998","journal-title":"Vet. Rec."},{"key":"10.1016\/j.pt.2016.03.002_bib0465","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-4017(00)00413-1","article-title":"An experimental study on triclabendazole resistance of Fasciola hepatica in sheep","volume":"95","author":"Gaasenbeek","year":"2001","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2016.03.002_bib0470","first-page":"200","article-title":"Triclabendazole resistant Fasciola hepatica in south-west Wales","volume":"146","author":"Thomas","year":"2000","journal-title":"Vet. Rec."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492216000441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492216000441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:31:57Z","timestamp":1761463917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492216000441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":94,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1471492216000441"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2016.03.002","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Threat of Triclabendazole Resistance in Fasciola hepatica","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2016.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}